These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10707123)

  • 21. Cross-resistance to beta-lactam-beta-lactamase inhibitor combinations and clindamycin among cefoxitin-resistant and cefoxitin-susceptible strains of the Bacteroides fragilis group.
    Aldridge KE
    Diagn Microbiol Infect Dis; 1993 Oct; 17(3):251-6. PubMed ID: 8112038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
    Pierard D; De Meyer A; Rosseel P; Van Cauwenbergh M; Struelens MJ; Delmee M; Goossens H; Claeys G; Glupczynski Y; Verbist L; Melin P; Lauwers S
    Acta Clin Belg; 1996; 51(2):70-9. PubMed ID: 8693871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial Susceptibility Patterns of Anaerobic Bacterial Clinical Isolates From 2014 to 2016, Including Recently Named or Renamed Species.
    Byun JH; Kim M; Lee Y; Lee K; Chong Y
    Ann Lab Med; 2019 Mar; 39(2):190-199. PubMed ID: 30430782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison of antimicrobial resistance patterns of enterotoxin gene positive and negative Bacteroides fragilis isolates].
    Toprak NU; Yağci A; Celik C; Cakici O; Söyletir G
    Mikrobiyol Bul; 2005 Apr; 39(2):145-52. PubMed ID: 16128024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
    Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
    Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW; Weeks LS; Aldridge KE
    Diagn Microbiol Infect Dis; 1992; 15(4):321-30. PubMed ID: 1611847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Characteristic of clinical strains of gram-negative obligate anaerobes].
    Kadzielska J; Kierzkowska M; Sawicka-Grzelak A; Rokosz A; Łuczak M
    Med Dosw Mikrobiol; 2007; 59(4):351-7. PubMed ID: 18416127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial susceptibility of anaerobic bacteria in Australia.
    Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
    J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility and beta-lactamase production of anaerobic and aerobic bacteria isolated from pus specimens from orofacial infections.
    Blandino G; Milazzo I; Fazio D; Puglisi S; Pisano M; Speciale A; Pappalardo S
    J Chemother; 2007 Oct; 19(5):495-9. PubMed ID: 18073147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.
    Hurlbut S; Cuchural GJ; Tally FP
    Antimicrob Agents Chemother; 1990 Jan; 34(1):117-20. PubMed ID: 2327745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C; Sánchez A; Gómez M; Palau ML; Picazo JJ
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.
    Aldridge KE; Sanders CV; Lewis AC; Marier RL
    J Med Microbiol; 1983 Feb; 16(1):75-82. PubMed ID: 6218305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phenotypic and genotypic characterization of multidrug-resistant Bacteroides, Parabacteroides spp., and Pseudoflavonifractor from a Costa Rican hospital.
    Molina J; Barrantes G; Quesada-Gómez C; Rodríguez C; Rodríguez-Cavallini E
    Microb Drug Resist; 2014 Oct; 20(5):478-84. PubMed ID: 24606061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical properties of beta-lactamase produced by Bacteroides distasonis.
    Asahi Y; Watanabe K; Ueno K
    J Antibiot (Tokyo); 1989 Jun; 42(6):960-7. PubMed ID: 2786864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An investigation of beta-lactamases from clinical isolates of Bacteroides species.
    Edwards R; Greenwood D
    J Med Microbiol; 1992 Feb; 36(2):89-95. PubMed ID: 1740789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
    Cherubin CE; Eng RH; Smith SM; Tan EN
    J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bactericidal activity of selected antimicrobial agents against Bilophila wadsworthia and Bacteroides gracilis.
    Baron EJ; Ropers G; Summanen P; Courcol RJ
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S339-43. PubMed ID: 8324144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do antimicrobial susceptibility patterns of colonic isolates of Bacteroides species change after antibiotic prophylaxis with cefoxitine during elective abdominal surgery?
    Toprak NU; Güllüoğlu BM; Cakici O; Akin ML; Demirkalem P; Celenk T; Söyletir G
    World J Surg; 2005 Oct; 29(10):1311-5. PubMed ID: 16142428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.